Skip to search formSkip to main contentSkip to account menu

Fenofibrate

Known as: Procetofene, Propanoic acid, 2-(4-(4-chlorobenzoyl)phenoxy)-2-methyl-, 1-methylethyl ester, Procetofen 
A synthetic phenoxy-isobutyric acid derivate and prodrug with antihyperlipidemic activity. Fenofibrate is hydrolyzed in vivo to its active metabolite… 
National Institutes of Health

Related topics

Related topics

41 relations

Narrower (15)

Antara Micronized ProcetofenFenofibrat AZUFenofibrat-ratiopharmFenofibrate micronized
Biliary cirrhosisCoronary Artery DiseaseDecreased Lipolysis [PE]Drug Allergy

Broader (1)

Hypolipidemic Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: An update.
Review
2013
Review
2013
Lipid-based formulations for oral administration of poorly water-soluble drugs.
Highly Cited
2011
Highly Cited
2011
Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid
Aliment Pharmacol Ther 2011; 33: 235–242 
Highly Cited
2009
Highly Cited
2009
Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats.
Review
2009
Review
2009
Peroxisome proliferator-activated receptor-alpha (PPARalpha): at the crossroads of obesity, diabetes and cardiovascular disease.
Highly Cited
2008
Highly Cited
2008
PPARα agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition
Angiogenesis and inflammation are central processes through which the tumor microenvironment influences tumor growth. We have… 
Review
2006
Review
2006
PPARs, Obesity, and Inflammation
The worldwide prevalence of obesity and related metabolic disorders is rising rapidly, increasing the burden on our healthcare… 
Highly Cited
2006
Highly Cited
2006
Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates.
Highly Cited
2003
Highly Cited
2003
Peroxisome Proliferator-Activated Receptor-α Activation as a Mechanism of Preventive Neuroprotection Induced by Chronic Fenofibrate Treatment
The treatment of ischemic strokes is limited to the prevention of cerebrovascular risk factors and to the modulation of the… 
Highly Cited
1985
Highly Cited
1985
The floppy Nissen fundoplication. Effective long-term control of pathologic reflux.
In 1976 we defined a technique of "floppy" Nissen fundoplication (FNF) that prevented experimental pathologic reflux without… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)